$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
白血病复发还能服用伊马替尼进行治疗吗?
2025-10-19 11:44:20
Check Details
甲氨蝶呤片可以用于急性淋巴细胞白血病的维持治疗吗?
2025-10-19 11:44:20
Check Details
急性淋巴细胞白血病吃甲氨蝶呤片能活多久?
2025-10-19 11:44:20
Check Details
用达希纳治疗白血病能活多久?
2025-10-19 11:44:20
Check Details
哪些白血病不适合使用达希纳?
2025-10-19 11:44:20
Check Details
使用达希纳治疗慢性髓性白血病的费用贵吗?
2025-10-19 11:44:20
Check Details
伊马替尼耐药后的选择-达希纳
2025-10-19 11:44:20
Check Details
白血病患者使用达希纳治疗时的禁忌和注意事项
2025-10-19 11:44:20
Check Details
雷德帕斯是FLT3突变阳性急性髓细胞白血病(AML)的突破治疗方案
2025-10-19 11:44:20
Check Details
白血病FJT3抑制剂富马酸吉列替尼图片及介绍
2025-10-19 11:44:20
Check Details
达希纳可以作为慢性髓性白血病的一线用药吗?
2025-10-19 11:44:20
Check Details
富马酸吉列替尼的出现,给白血病患者带来了新的选择
2025-10-19 11:44:20
Check Details
1
2
...
605
606
607
608
609
610
611
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
2
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
3
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
4
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
5
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
6
A Key Therapeutic Breakthrough Against T315I-Mutant CML
7
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
8
Tafasitamab and Lenalidomide Combination Therapy Guide
9
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
10
Gilteritinib Professional Medication Guide & Dosage Management
11
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
12
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia